- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Cavan Ventures Welcomes Dr. Manju Sharma, MD and Doctor of Naturopathy, to Board
Cavan Ventures Inc. (TSXV:CVN) has appointed Dr. Manju Sharma, MD and Doctor of Naturopathy, to its advisory board.
Cavan Ventures Inc. (TSXV:CVN) has appointed Dr. Manju Sharma, MD and Doctor of Naturopathy, to its advisory board. The appointment is a key part of Cavan’s efforts to accelerate the diversification of its growth plan into the medical marijuana and hemp industry.
As quoted in the press release:
Dr. Manju Sharma is a medical doctor, working currently as a scientist at Vancouver Prostate Centre, Vancouver General Hospital for the last 5 years. Prior to this she worked in the department of Pathology and Lab Medicine, VGH for 10 years on various projects including molecular diagnosis of tuberculosis, multi-drug resistant tuberculosis, human solid tumors, kidney disorders, medicinal herbal plants like Echinacea which is widely used all over Europe and North America for the treatment of cough and cold: active principles and their mode of action on various human viral and bacterial diseases. She has published over 70 papers in medical journals and has made several presentations in the field of Medicine.
Click here to read the full Cavan Ventures Inc. (TSXV:CVN) press release.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.